In this regard, Taketa et al. [20] demonstrated, in a mouse model of Alzheimer’s disease, how peripheral injection of LPS increased TNFα and IL-6 concentrations in the brain, as well as it did in the permeability of the blood–brain barrier and how it entailed behavioral impairment. This evidence concerns the gene IL6 and early-onset autosomal dominant Alzheimer disease.